SummitTX Capital »

Beam Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $393k 16k 24.27
2025-03-31 $459k 24k 19.53

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Cisco Systems (CSCO)
MKS Instruments (MKSI)
NVIDIA Corporation (NVDA)
Cyberark Software SHS (CYBR)
PPL Corporation (PPL)
Meritage Homes Corporation (MTH)
Toll Brothers (TOL)
Teradyne (TER)
Applied Materials (AMAT)
Griffon Corporation (GFF)
Owens Corning (OC)

View all positions for SummitTX Capital

Top funds holding Beam Therapeutics

FMR
ARK Investment Management
Farallon Capital Management
Vanguard Group
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Arch Venture Corp
State Street Corporation
Bellevue Group
Kynam Capital Management
Geode Capital Management
MWG Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics